NEW YORK — In this Healio Video Perspective from the ASRS meeting, John Kitchens, MD, discusses results from the phase 3 YOSEMITE and RHINE trials. Results showed that treat-and-extend-based personal treatment interval dosing was effective for optimizing faricimab in patients with diabetic macular edema.